Executive Director, Clinical Development
Replimune, Inc.
Dr. Cohan is a Diplomate of the American Board of Surgery and a Fellow of SSO, ACS, and AHNS. He is fellowship trained in head & neck surgical oncology and plastic and reconstructive surgery. Dr. Cohan spent the majority of his career in adacemic clinical practice in the Department of Head & Neck and Plastic & Reconstructive Surgery at Roswell Park Cancer Institute. In 2017, Dr. Cohan left clinical practice to co-lead the T-VEC Program and subsequently the blinotumumab Program at Amgen. Since 2019, Dr. Cohan has worked at a variety of smaller biotech companies designing clinical development strategies and writing and managing clinical trials in both the hemato-oncology and soild tumor spaces. Dr. Cohan is currently an Executive Director for Clinical Development at Replimune. He attended Yale College and the Stanford University School of Medicine.
Thursday, March 23, 2023
11:00 AM – 11:20 AM
Disclosure information not submitted.